Quick Summary

Anemarrhena asphodeloides is a traditional Chinese medicinal herb recognized for its bioactive steroidal saponins and polysaccharides. It has been studied for various pharmacological effects including antidiabetic, anti-inflammatory, neuroprotective, and potential antidepressant properties. Clinical evidence specific to Anemarrhena alone is limited, with most use occurring in combination with other herbs in traditional formulae. Current research primarily supports possible adjunctive benefits in metabolic, inflammatory, and neuropsychiatric conditions, based mainly on preclinical studies and some clinical trials involving multi-herb formulations.

What Is It?

Anemarrhena asphodeloides is a herb used in traditional Chinese medicine derived from the rhizome of the Anemarrhena plant. It contains bioactive compounds, particularly steroidal saponins and polysaccharides, believed to contribute to its medicinal properties.

Traditional Uses

Traditionally, Anemarrhena is employed within Chinese herbal formulations for supporting metabolic health, modulating inflammation, enhancing immune function, and addressing neuropsychiatric conditions such as depression. It is rarely used as a single herb but typically combined with other botanicals in complex prescriptions.

Active Compounds

  • Steroidal saponins: Compounds such as Timosaponin AIII are considered major bioactive constituents.
  • Polysaccharides: Polysaccharide extracts are studied for immunomodulatory and anti-inflammatory effects.

Potential Benefits with Evidence Levels

  • Possible adjuvant treatment for diabetic nephropathy (moderate evidence): A systematic review and meta-analysis of Jinlida granules (which include Anemarrhena) reported improvements in renal function and glucose metabolism markers from 13 randomized controlled trials (n=1333). However, these findings pertain to a compound product rather than Anemarrhena alone, and evidence on safety superiority was not definitive.
  • Possible benefits in type 2 diabetes management (low to moderate evidence): A Bayesian network meta-analysis of classical botanical formulas combined with metformin identified formulations containing Anemarrhena components as potentially improving glycemic control in type 2 diabetes patients (40 RCTs, n=3088). Safety data were limited, with many trials underreporting adverse events.
  • Potential antidepressant effects in traditional formulae (preclinical and some clinical evidence): The Baihe Zhimu decoction, which contains Anemarrhena, is traditionally used for depression. Some experimental and limited clinical data support potential antidepressant effects, though mechanistic insights are mainly from preclinical studies and clinical trials generally involve multiple herbs.
  • Possible immune and anti-inflammatory modulation (preclinical evidence): Studies of polysaccharides and saponins from Anemarrhena demonstrate immunomodulatory and anti-inflammatory effects in vitro and animal models. Clinical evidence specific to Anemarrhena is limited.

Side Effects

No significant or serious adverse effects have been definitively linked to Anemarrhena monotherapy. Reports from compound herbal formulas indicate no increased incidence of adverse reactions compared to controls. Detailed adverse effect profiles specific to Anemarrhena alone are lacking.

Drug Interactions

There is no direct clinical evidence regarding drug interactions involving Anemarrhena. Due to common use alongside conventional treatments, there is potential for interactions, but these remain uncharacterized in clinical studies.

Who Should Avoid It

There are no specific contraindications identified in current literature. However, caution is advised for individuals considering Anemarrhena monotherapy due to limited safety data. Pregnant or breastfeeding individuals should avoid use given insufficient safety information.

Evidence Limitations

Most clinical investigations involve Anemarrhena as part of multi-herb formulations rather than as a single agent, making it difficult to attribute effects specifically to this herb. Many studies have methodological limitations including small sample sizes, potential bias, underreporting of adverse events, and high heterogeneity between trials. Mechanistic and pharmacological insights mainly derive from preclinical research. Safety and efficacy in pregnancy and lactation remain unstudied.

References

  • Dai B, Chen Y, Xiao Y, et al. (2026). Efficacy and safety of Jinlida granules as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis. Europe PMC. PMID 41767388, DOI: 10.3389/fendo.2026.1740623
  • Che L, Dong W, Liu Y, Guo H. (2026). Efficacy and safety of traditional Chinese classic prescriptions combined with metformin in the treatment of type 2 diabetes mellitus: a Bayesian network meta-analysis. Europe PMC. PMID 41756240, DOI: 10.3389/fphar.2026.1693378
  • Pan W, Shi H, Zang Z, et al. (2024). Research progress on classical traditional Chinese medicine formula Baihe Zhimu (Lilium lancifolium bulb and Anemarrhena asphodeloides rhizome) decoction in the treatment of depression. Europe PMC. PMID 38352746, DOI: 10.1016/j.heliyon.2024.e25171
  • Scientific Article. (2021). Purification, characterization and immunostimulatory effects of polysaccharides from Anemarrhena asphodeloides rhizomes. International Journal of Biological Macromolecules. DOI: 10.1016/j.ijbiomac.2021.01.088
  • Scientific Article. (2020). Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review. Frontiers in Pharmacology. DOI: 10.3389/fphar.2020.00764

Last Reviewed

April 2024


Disclaimer: This information is provided for educational purposes and does not constitute medical advice. Anemarrhena and related products should not replace consultation with a qualified healthcare professional. Evidence for benefits and safety is limited or preliminary, particularly regarding use as a single herb. Individuals should discuss any herbal supplementation with their healthcare provider before use.